Immunotherapy Implication of Signature-Guided Biomarker Discovery for Trastuzumab-Resistant HER2-Positive Breast Cancer
Andrea Sand, Aspen T. Duffin, Geoffrey T. Riddell, Mitchel Piacsek, Brittany Last, View ORCID ProfileChaoyang Sun, Richard A. Rovin, Judy A. Tjoe, View ORCID ProfileJun Yin
doi: https://doi.org/10.1101/2020.01.17.20017947
Andrea Sand
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
MSAspen T. Duffin
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
BSGeoffrey T. Riddell
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
BSMitchel Piacsek
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
BSBrittany Last
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
2Biorepository and Specimen Resource Center (BSRC), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
BSChaoyang Sun
3Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
PhDRichard A. Rovin
4Aurora Neuroscience Innovation Institute, Aurora St. Luke’s Medical Center, Milwaukee, WI 50302, USA
MDJudy A. Tjoe
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
5Comprehensive Breast Care Center, Aurora Sinai Medical Center, Advocate Aurora Health, Milwaukee, WI 53233, USA
MDJun Yin
1Translational Oncology Research: Quest for Understanding & Exploration (TORQUE), Advocate Aurora Health Research Institute, Milwaukee, WI 53233, USA
PhDArticle usage
Posted January 24, 2020.
Immunotherapy Implication of Signature-Guided Biomarker Discovery for Trastuzumab-Resistant HER2-Positive Breast Cancer
Andrea Sand, Aspen T. Duffin, Geoffrey T. Riddell, Mitchel Piacsek, Brittany Last, Chaoyang Sun, Richard A. Rovin, Judy A. Tjoe, Jun Yin
medRxiv 2020.01.17.20017947; doi: https://doi.org/10.1101/2020.01.17.20017947
Immunotherapy Implication of Signature-Guided Biomarker Discovery for Trastuzumab-Resistant HER2-Positive Breast Cancer
Andrea Sand, Aspen T. Duffin, Geoffrey T. Riddell, Mitchel Piacsek, Brittany Last, Chaoyang Sun, Richard A. Rovin, Judy A. Tjoe, Jun Yin
medRxiv 2020.01.17.20017947; doi: https://doi.org/10.1101/2020.01.17.20017947
Subject Area
Subject Areas
- Addiction Medicine (359)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2702)
- Dermatology (231)
- Emergency Medicine (408)
- Epidemiology (12343)
- Forensic Medicine (10)
- Gastroenterology (774)
- Genetic and Genomic Medicine (4188)
- Geriatric Medicine (394)
- Health Economics (690)
- Health Informatics (2708)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (869)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (447)
- Neurology (3974)
- Nursing (216)
- Nutrition (587)
- Oncology (2093)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1137)
- Primary Care Research (464)
- Public and Global Health (6603)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)